EFOR

Despite a secular uptrend, weakening intermediate structure in a Stage 3 distribution phase and a confirmed double top with support failure signal that selling is favored. The recent breakdown below the 20EMA with follow-through and exhaustion from overbought conditions suggests exiting positions now. A supportive 50SMA lies well below, but until price reclaims the neckline and EMAs, bearish posture remains appropriate.

• ↑Secured $30M Defense Health Agency contract to modernize IT
• ↑Upgraded to Strong Buy by Zacks, driven by positive analyst revisions
• ↓Negative growth metrics limit market expansion potential